The vascular targeting agent combretastatin-A4 and a novel cis-Restricted {beta}-Lactam Analogue, CA-432, induce apoptosis in human chronic myeloid leukemia cells and ex vivo patient samples including those displaying multidrug resistance
Lisa M Greene, Seema M Nathwani, Sandra A Bright, Darren Fayne, Aisling Croke, Maria Gagliardi, Anthony M McElligott, Lisa O'Connor, Miriam Carr, Niall O Keely, Niamh M O'Boyle, Peig Carroll, Balazs Sarkadi, Eibhlin Conneally, David G Lloyd, Mark Lawler, Mary J Meegan, Daniela M Zisterer, Mark Lawler
Fingerprint
Dive into the research topics of 'The vascular targeting agent combretastatin-A4 and a novel cis-Restricted {beta}-Lactam Analogue, CA-432, induce apoptosis in human chronic myeloid leukemia cells and ex vivo patient samples including those displaying multidrug resistance'. Together they form a unique fingerprint.